Collectively, upregulation of the Ang II/AT1R interaction, the shift in the OPG/RANKL ratio and the increase in aldosterone contribute to decreased bone mineral density (BMD) [11], consequently altering the microarchitecture of the bone structure and leading to the development and progression of osteoporosis [11]. The gene discussed is TNFRSF11B; the disease is osteoporosis.